Dow Up1.31% Nasdaq Up2.40%

Regulus Therapeutics Inc. (RGLS)

-NasdaqGM
6.77 Down 0.05(0.73%) Oct 21, 4:00PM EDT
Balance SheetGet Balance Sheet for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Assets
Current Assets
Cash And Cash Equivalents17,807  40,552  9,175  
Short Term Investments96,198  57,548  28,969  
Net Receivables79   -   -  
Inventory -   -   -  
Other Current Assets3,098  829  522  
Total Current Assets 117,182   98,929   38,666  
Long Term Investments -   -   -  
Property Plant and Equipment3,768  3,310  3,110  
Goodwill -   -   -  
Intangible Assets1,128  1,154  980  
Accumulated Amortization -   -   -  
Other Assets987  125  125  
Deferred Long Term Asset Charges -   -   -  
Total Assets 123,065   103,518   42,881  
Liabilities
Current Liabilities
Accounts Payable5,482  2,317  2,115  
Short/Current Long Term Debt -   -   -  
Other Current Liabilities4,888  10,451  10,735  
Total Current Liabilities 10,370   12,768   12,850  
Long Term Debt11,279  10,134  10,000  
Other Liabilities1,459  767  1,847  
Deferred Long Term Liability Charges6,500  17,756  16,987  
Minority Interest -   -   -  
Negative Goodwill -   -   -  
Total Liabilities 29,608   41,425   41,684  
Stockholders' Equity
Misc Stocks Options Warrants -   -  42,691  
Redeemable Preferred Stock -   -   -  
Preferred Stock -   -   -  
Common Stock42  36   -  
Retained Earnings(79,087)(60,419)(43,011)
Treasury Stock -   -   -  
Capital Surplus172,518  122,528  1,584  
Other Stockholder Equity(16)(52)(67)
Total Stockholder Equity 93,457   62,093   (41,494)
Net Tangible Assets 92,329   60,939   (42,474)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.